This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
C3_MALE_GENITAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
21788 |
6. Filter based on genotype QC (FinnGen only) |
21788 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21788 | - | 21788 |
| Unadjusted period prevalence (%) | 9.61 | - | 9.61 |
| Median age at first event (years) | 68.86 | - | 68.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4429
- Matched controls
- 37114
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
154.3
323.0
619
39
C61
ICD-10 Finland
Malignant neoplasm of prostate
13890.4
323.0
3893
10
JN4BD
NOMESCO Finland
Extensive body CT
10.6
323.0
897
864
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
1434
*
L02BB03
ATC
bicalutamide; oral
+∞
323.0
444
*
L02AE02
ATC
leuprorelin; implant, parenteral
9016.3
323.0
877
*
ZXC96
NOMESCO Finland
Robot assisted procedure
235.0
323.0
1083
51
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
323.0
431
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
17.6
323.0
566
307
XKD00
NOMESCO Finland
Uroflowmetry
11.0
323.0
2358
3477
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
6.6
323.0
1213
2008
L02BX02
ATC
degarelix; parenteral
+∞
323.0
342
*
KC1GB
NOMESCO Finland
Cystography with X-ray
342.5
323.0
377
10
XX3DW
NOMESCO Finland
Time consuming IT work
16.0
323.0
1100
751
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
331
*
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
24.9
323.0
700
278
H02AB02
ATC
dexamethasone; systemic
38.0
323.0
493
122
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
323.0
623
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
5458.6
323.0
578
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
25.0
323.0
1557
788
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.6
323.0
2006
5622
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
9.8
323.0
1950
2761
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
3927
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
278.6
323.0
526
18
Y77
ICPC
Malignant neoplasm prostate
1419.0
323.0
710
5
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
323.0
1678
*
WF002
NOMESCO Finland
Radical radiotherapy
830.4
323.0
1117
15
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
70.2
323.0
2279
551
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
500.7
316.6
333
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
329.3
308.9
330
9
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
720.8
307.2
320
*
JN4AD
NOMESCO Finland
Body CT examination
11.4
304.0
623
524
G04BE03
ATC
sildenafil; oral
42.8
300.6
397
85
KFC00
NOMESCO Finland
Unilateral orchiectomy
75.6
296.6
357
43
J01EA01
ATC
trimethoprim; systemic
6.9
292.2
822
1179
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
32.3
290.3
408
116
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
280.6
285
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
279.6
284
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2467.1
278.2
285
*
A04AA02
ATC
granisetron; systemic, transdermal
370.4
273.4
291
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
506.6
269.7
284
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
262.7
267
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2287.7
259.3
266
*
G04BE01
ATC
alprostadil; parenteral, urethral
29.3
254.9
367
114
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
237.8
242
*
KE1BG
NOMESCO Finland
MRI of prostate
40.6
233.8
312
69
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
231.5
739
1227
KDE20
NOMESCO Finland
Removal of foreign body from urethra
81.2
228.7
273
30
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
46.7
228.6
297
57
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
219.0
223
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
164.8
217.1
242
13
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
376.5
201.6
215
5
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
27.0
199.4
293
97
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
197.2
201
*
L02BB04
ATC
enzalutamide; oral
+∞
195.2
199
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
193.0
1469
5260
ZX090
NOMESCO Finland
Other technic of radiotherapy
565.0
184.3
194
*
L02AE04
ATC
triptorelin; parenteral
+∞
181.3
185
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
24.9
173.8
261
93
KE1CG
NOMESCO Finland
Extensive MRI of prostate
43.7
173.4
228
46
B01AB05
ATC
enoxaparin; parenteral
2.9
173.4
1409
5191
WZC30
NOMESCO Finland
Teaching
3.9
165.0
788
1944
XJH00
NOMESCO Finland
Transanal ultrasonography
5.6
163.2
534
892
KEB00
NOMESCO Finland
Biopsy of prostate
34.1
159.6
221
57
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
158.6
162
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
158.2
998
3066
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
156.6
160
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
1431.2
154.5
160
*
M05BX04
ATC
denosumab; parenteral
21.0
150.7
238
100
G04CA02
ATC
tamsulosin; oral
2.5
150.2
1661
7196
L03AA13
ATC
pegfilgrastim; parenteral
671.4
147.7
155
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
145.8
149
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
37.5
145.3
197
46
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.4
141.9
287
225
UKC02
NOMESCO Finland
Cystoscopy
3.2
139.6
883
2690
WX402
NOMESCO Finland
General anaesthesia
3.1
139.6
931
2945
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
135.0
138
*
J01MA02
ATC
ciprofloxacin; systemic
2.3
131.6
1878
9085
ZX080
NOMESCO Finland
Image guided radiotherapy
590.7
130.1
137
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
123.2
126
*
N40
ICD-10 Finland
Hyperplasia of prostate
2.3
123.1
1485
6568
TKE10
NOMESCO Finland
Puncture of prostate
191.3
120.4
133
6
N39.3
ICD-10 Finland
Stress incontinence
86.5
118.2
140
14
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
271.4
115.3
125
*
L02BX03
ATC
abiraterone; oral
+∞
115.3
118
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
114.3
117
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
1023.2
114.3
119
*
WF004
NOMESCO Finland
Palliative radiotherapy
996.7
111.3
116
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
110.6
3655
24746
OAB42
NOMESCO Finland
Guidance related to known health problem
92.0
108.8
128
12
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
107.4
110
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
105.5
108
*
TQW40
NOMESCO Finland
Remowal of suture of skin
3.8
103.5
486
1151
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
101.6
104
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
97.6
100
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
12.7
96.6
184
126
Z51.5
ICD-10 Finland
Palliative care
13.3
95.9
179
117
A04AA01
ATC
ondansetron; systemic, rectal
9.9
93.4
201
177
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
218.8
93.1
102
*
3054
Kela drug reimbursment
NA
+∞
92.7
95
*
L03AA02
ATC
filgrastim; parenteral
102.0
92.0
107
9
1523
Kela drug reimbursment
NA
+∞
91.8
94
*
JN4CD
NOMESCO Finland
Very extensive body CT
8.5
83.5
196
201
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
81.0
83
*
Z51.0
ICD-10 Finland
Radiotherapy session
716.0
80.1
84
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
78.0
80
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
243.0
78.0
85
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
672.5
75.2
79
*
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
174.9
73.9
82
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
73.1
75
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
71.2
73
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
68.5
1943
11321
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
6.8
68.0
184
235
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
210.0
67.4
74
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
603.1
67.4
71
*
ZX112
NOMESCO Finland
Subcutaneous
12.2
66.5
128
90
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
66.3
68
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
65.3
67
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
65.3
67
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
155.4
65.2
73
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
64.3
66
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
64.3
66
*
N02AA05
ATC
oxycodone; systemic
2.8
64.0
468
1512
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
64.0
627
2388
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
63.4
65
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
36.8
60.7
82
19
B01AB10
ATC
tinzaparin; parenteral
4.1
60.0
255
546
R31
ICD-10 Finland
Unspecified haematuria
2.7
59.7
473
1601
G04BD12
ATC
mirabegron; oral
2.9
57.7
381
1150
A79
ICPC
Malignancy NOS
516.7
57.7
61
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
135.9
56.7
64
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.2
55.6
227
468
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
55.4
1683
9810
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.0
54.9
74
17
A04AA55
ATC
palonosetron, combinations; systemic
+∞
54.6
56
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
54.6
56
*
A04AD12
ATC
aprepitant; systemic
473.6
52.9
56
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
61.5
52.7
65
9
L01BC06
ATC
capecitabine; oral
+∞
52.6
54
*
L02AE03
ATC
goserelin; implant
+∞
52.6
54
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
15.4
51.7
90
50
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
51.6
53
*
Y06
ICPC
Prostate symptom/complaint
3.9
51.1
230
518
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
50.7
52
*
U04
ICPC
Incontinence urine
6.3
50.6
143
194
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
50.4
318
929
R33
ICD-10 Finland
Retention of urine
2.8
50.0
349
1090
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
49.7
51
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
49.0
1361
7656
PJA12
NOMESCO Finland
Sentinel node biopsy
430.6
48.0
51
*
KCC10
NOMESCO Finland
Cystoprostatectomy
430.6
48.0
51
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
47.5
435
1586
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.4
45.3
235
595
XX1AD
NOMESCO Finland
Other CT-examination
76.3
45.2
54
6
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.2
45.1
75
37
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
44.8
46
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
44.8
46
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
52.7
44.5
56
9
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
396.3
44.1
47
*
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
32.4
44.1
61
16
G03HA01
ATC
cyproterone; systemic
23.4
43.8
66
24
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
+∞
43.8
45
*
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
43.8
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
43.8
45
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
42.8
44
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
42.8
44
*
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
+∞
42.8
44
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
379.1
42.2
45
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
28.9
40.9
58
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
129.7
40.7
46
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
39.9
41
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
38.9
40
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
38.9
40
*
J01MA12
ATC
levofloxacin; systemic
1.9
38.6
706
3439
G04CA01
ATC
alfuzosin; oral
1.8
37.6
840
4369
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
173.2
37.1
41
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
37.0
327
1165
KDW96
NOMESCO Finland
Other operations on urethra
90.9
36.8
43
*
WW500
NOMESCO Finland
Blood transfusion
5.1
36.8
122
203
XKG00
NOMESCO Finland
Artificial induction of erection
26.4
36.5
53
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
36.3
1662
10436
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
48.6
36.2
46
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.9
36.0
157
344
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
36.0
37
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
35.3
412
1680
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
164.7
35.2
39
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
51.9
34.2
43
7
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
156.2
33.2
37
*
A06AH03
ATC
naloxegol; oral
24.4
33.1
49
17
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
33.1
34
*
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
33.1
34
*
TKC22
NOMESCO Finland
Catheterisation instruction
4.1
33.0
137
288
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
293.5
32.6
35
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
44.4
32.5
42
8
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.5
32.3
74
74
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
11.4
32.1
63
47
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
32.1
33
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
32.1
33
*
G04BD08
ATC
solifenacin; oral
3.0
32.1
199
574
WVA20
NOMESCO Finland
Medicine administration
4.3
31.5
124
248
G04BE09
ATC
vardenafil; oral
54.8
31.3
39
6
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
31.1
32
*
2BX02
NOMESCO Finland
NA
+∞
31.1
32
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.1
32
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.5
30.9
53
29
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
12.5
29.9
56
38
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.2
29.6
84
116
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
29.2
30
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
29.2
30
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
28.8
742
3988
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
12.4
28.7
54
37
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
263.5
28.7
31
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.7
28.5
86
129
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
28.2
29
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.5
27.9
139
342
ZXC20
NOMESCO Finland
Use of chemical agents
8.9
27.5
61
58
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
27.4
316
1277
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
27.2
28
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
27.2
28
*
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
9.9
27.2
57
49
KED22
NOMESCO Finland
Transurethral resection of prostate
2.5
26.6
227
792
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
26.3
27
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
26.3
27
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
26.3
27
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
26.0
25.6
37
12
WX704
NOMESCO Finland
Intubation
2.2
25.1
272
1068
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
24.3
25
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
24.3
25
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
113.7
23.8
27
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
23.8
254
994
WF099
NOMESCO Finland
Other radiotherapy
21.7
23.7
36
14
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
23.4
24
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
23.4
24
*
Y78
ICPC
Malign neopl male genital other
+∞
23.4
24
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.4
24
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
23.4
24
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
109.5
22.8
26
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
22.4
23
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
22.4
23
*
1CD02
NOMESCO Finland
NA
+∞
22.4
23
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.0
22.3
74
125
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
22.2
195
693
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
22.0
358
1658
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
202.0
22.0
24
*
WX110
NOMESCO Finland
Local anesthesy
1.4
21.8
2646
19293
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
21.4
22
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
21.4
22
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
4.9
21.1
71
122
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
70.2
21.0
25
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
20.7
602
3318
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
21.8
20.6
31
12
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
20.4
21
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
29.5
20.1
28
8
R4110
NOMESCO Finland
Physiotherapy
1.5
20.0
914
5584
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.7
20.0
70
126
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
16.4
19.9
33
17
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
19.8
112
304
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
19.5
20
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
19.5
20
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.3
19.3
44
45
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.6
19.1
143
466
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
92.6
19.1
22
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.2
19.0
61
100
N30.4
ICD-10 Finland
Irradiation cystitis
+∞
18.5
19
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
18.5
19
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
18.5
19
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
88.4
18.1
21
*
JN6AD
NOMESCO Finland
CT of torso and neck
8.9
17.9
39
37
R50.9
ICD-10 Finland
Fever, unspecified
1.7
17.9
415
2150
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
17.8
71
146
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
17.5
18
*
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
17.5
18
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.5
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
59.0
17.3
21
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
10.6
17.2
34
27
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
8.2
17.1
39
40
WX320
NOMESCO Finland
Spinalanesthesy
1.5
16.7
724
4363
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
16.5
17
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
16.5
17
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
16.5
17
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
16.5
17
*
R39.1
ICD-10 Finland
Other difficulties with micturition
2.3
16.3
150
547
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
151.3
16.3
18
*
KA1FN
NOMESCO Finland
Isotope renography
7.5
16.2
39
44
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
22.4
16.2
24
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.3
16.1
160
607
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
15.9
103
310
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
15.8
209
896
TJF80
NOMESCO Finland
Ostomy education
12.2
15.7
29
20
ZX120
NOMESCO Finland
Intravenous
1.9
15.6
243
1107
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
15.6
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
15.6
16
*
XX1XQ
NOMESCO Finland
Other SPECT-CT
+∞
15.6
16
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
15.6
16
*
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
15.6
16
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
26.4
15.5
22
7
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
26.4
15.5
22
7
NK6SN
NOMESCO Finland
Bone SPECT
75.7
15.3
18
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
15.0
544
6255
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.4
14.8
129
458
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
14.6
15
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
14.6
15
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
134.5
14.4
16
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
28.0
14.4
20
6
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.4
14.0
118
412
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.4
14.0
31
31
121
Kela drug reimbursment
Severe hypofunction of sexual glands
4.2
13.9
53
106
XKC03
NOMESCO Finland
Water cystometry
2.9
13.8
85
248
KA3EB
NOMESCO Finland
Antegrade pyelography
8.7
13.8
30
29
ZX100
NOMESCO Finland
Oral
4.4
13.7
50
96
D29.2
ICD-10 Finland
Benign neoplasm: Testis
14.9
13.6
23
13
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
47.6
13.6
17
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
13.6
14
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
13.6
14
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
126.0
13.4
15
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
126.0
13.4
15
*
SPAT1262
SPAT
Handing over of treatment supplies
1.4
13.1
676
4195
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.9
13.0
24
17
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
12.6
13
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
12.6
13
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.6
13
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.6
13
*
C61, D400
ICD-10 Finland
NA
+∞
12.6
13
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
12.6
13
*
U76
ICPC
Malignant neoplasm of bladder
+∞
12.6
13
*
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
12.6
13
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
117.6
12.5
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
12.4
393
2205
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
5.3
12.3
38
61
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
13.6
12.1
21
13
WX600
NOMESCO Finland
Single shot through catheter
7.2
11.9
29
34
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
11.8
1166
8006
WVA30
SPAT
NA
2.2
11.8
117
447
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
11.7
12
*
U77
ICPC
Malignant neopl urinary tract other
+∞
11.7
12
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
11.7
12
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
11.7
12
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
11.7
12
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.7
12
*
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
+∞
11.7
12
*
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
11.7
12
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
14.0
11.7
20
12
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
11.6
112
1737
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
11.5
277
1451
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
11.8
11.4
21
15
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
11.3
214
1042
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
14.5
11.3
19
11
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
31.5
11.2
15
*
KCW96
NOMESCO Finland
Other operations on bladder
8.1
11.1
25
26
G04CB02
ATC
dutasteride; oral
1.7
11.1
256
1324
ZX136
NOMESCO Finland
Intravesicalis
11.0
11.1
21
16
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
5.0
11.0
35
59
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
22.4
11.0
16
6
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.0
10.8
63
179
WF001
NOMESCO Finland
Preoperative radiotherapy
54.5
10.7
13
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.7
11
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
10.7
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
10.7
11
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
10.7
11
*
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
+∞
10.7
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.7
11
*
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
10.7
11
*
C90.0
ICD-10 Finland
Multiple myeloma
100.8
10.6
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
100.8
10.6
12
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.6
10.4
76
248
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
10.3
348
1979
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
10.2
14
483
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.6
10.2
75
246
U08
ICPC
Urinary retention
2.7
10.1
68
213
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
10.1
3795
30347
Z3231
NOMESCO Finland
Registered nurse
1.3
9.9
843
5648
TQX05
NOMESCO Finland
Skin puncture, unspecified location
10.6
9.9
19
15
A02BC02
ATC
pantoprazole; systemic
1.2
9.9
2236
16830
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
9.7
10
*
L02BB01
ATC
flutamide; oral
+∞
9.7
10
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
9.7
10
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
9.7
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
92.4
9.7
11
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
92.4
9.7
11
*
SPAT1153
SPAT
Removal of sutures
1.3
9.7
1009
6948
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
5.2
9.5
29
47
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
9.5
71
236
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
9.2
162
775
U06
ICPC
Haematuria
2.6
9.2
67
220
WW200
SPAT
NA
0.6
9.2
194
2482
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
33.6
9.1
12
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
33.6
9.1
12
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
9.0
71
242
N05AX08
ATC
risperidone; systemic
0.5
9.0
72
1178
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.0
9.0
20
21
P72
ICPC
Schizophrenia
0.2
8.9
12
417
KGD00
NOMESCO Finland
Partial excision of glans penis
46.2
8.9
11
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
8.9
18
505
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.8
8.8
37
83
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.6
8.8
39
92
ZX137
NOMESCO Finland
To penis
+∞
8.8
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.8
9
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
8.8
9
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.8
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
8.8
9
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
8.8
9
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
8.8
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
8.8
9
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.8
9
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
8.8
9
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
8.8
9
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.8
9
*
KGD05
NOMESCO Finland
Partial excision of body of penis
83.9
8.7
10
*
OAA41
NOMESCO Finland
Health check based on individual needs
83.9
8.7
10
*
U99
ICPC
Urinary disease other
5.5
8.7
25
38
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.2
8.6
26
42
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.1
8.6
99
405
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
8.5
48
134
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
18.2
8.5
13
6
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
18.2
8.5
13
6
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
9.5
8.5
17
15
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
5.6
8.5
24
36
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
8.5
733
7504
N30.9
ICD-10 Finland
Cystitis, unspecified
2.5
8.4
64
215
N42.8
ICD-10 Finland
Other specified disorders of prostate
4.3
8.3
30
59
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.1
8.1
14
9
N05AA02
ATC
levomepromazine; systemic
0.5
8.1
60
1004
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
9.6
8.0
16
14
B01AB04
ATC
dalteparin; parenteral
2.0
8.0
102
438
N48.4
ICD-10 Finland
Impotence of organic origin
1.8
8.0
142
683
4194
NOMESCO Finland
NA
42.0
8.0
10
*
UJF32
NOMESCO Finland
Coloscopy
1.3
8.0
697
4678
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.5
8.0
36
87
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
7.6
7.9
18
20
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
7.9
470
5046
5703
FHL
Removal of lymph nodes from the retroperitoneal space
75.6
7.8
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.8
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
7.8
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.8
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.8
8
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
7.8
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.8
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.8
8
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
7.8
8
*
5BX04
NOMESCO Finland
NA
+∞
7.8
8
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
7.8
8
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
7.8
8
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.8
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
7.8
8
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.4
7.8
31
643
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
23.1
7.7
11
*
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
23.1
7.7
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
7.7
1405
10262
A10AA02
ATC
NA
0.4
7.6
24
550
N41.0
ICD-10 Finland
Acute prostatitis
1.8
7.6
127
598
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
7.5
68
252
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
7.5
509
3291
J01CA08
ATC
pivmecillinam; oral
1.9
7.5
112
510
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
7.5
161
819
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
7.5
7.5
17
19
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.9
7.5
18
22
N05AC02
ATC
thioridazine; oral
0.3
7.4
13
393
WW409
NOMESCO Finland
Other aferesis
28.0
7.4
10
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
7.4
148
740
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
5.1
7.3
22
36
KGB00
NOMESCO Finland
Biopsy of penis
6.1
7.3
19
26
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.1
7.3
38
103
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.1
7.2
17
20
ZXE00
NOMESCO Finland
One hour or less
1.2
7.2
1170
8434
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
7.1
99
440
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.1
125
599
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
37.7
7.1
9
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
37.7
7.1
9
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
7.5
7.0
16
18
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
7.0
725
7299
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
7.0
22
501
N05AH02
ATC
clozapine; systemic
0.3
6.9
15
405
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.9
6.9
41
121
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.6
6.9
85
1229
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
6.9
137
684
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
21.0
6.9
10
*
XW000
NOMESCO Finland
Bone marrow biopsy
2.1
6.9
76
310
N03AG01
ATC
valproic acid; systemic, rectal
0.6
6.9
76
1131
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
221
1250
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.8
7
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
6.8
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.8
7
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
6.8
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.8
7
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.8
7
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.8
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.8
7
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.8
7
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.8
7
*
L01CB01
ATC
etoposide; systemic
+∞
6.8
7
*
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
+∞
6.8
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.8
7
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
6.8
7
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.5
6.8
52
858
ECB20
NOMESCO Finland
Oral alveoplasty
2.9
6.8
40
118
B01AC04
ATC
clopidogrel; oral
0.7
6.8
324
3592
N04AA02
ATC
biperiden; systemic
0.3
6.8
17
430
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.5
6.7
51
174
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.8
6.7
108
505
KDV10
NOMESCO Finland
Internal urethrotomy
3.1
6.7
35
96
KAC10
NOMESCO Finland
Total nephrectomy with capsule
8.4
6.6
14
14
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
5.3
6.6
19
30
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.0
6.6
35
97
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
6.6
68
268
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
25.2
6.5
9
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.6
6.5
153
800
A10AA01
ATC
NA
0.4
6.5
22
488
G04BE08
ATC
tadalafil; oral
9.1
6.5
13
12
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
6.0
6.5
17
24
KFA00
NOMESCO Finland
Exploration of testis
4.4
6.4
22
42
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.8
6.4
41
125
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
6.4
402
2573
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.4
296
1801
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.4
6.4
31
597
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
6.3
111
536
C05AA08
ATC
fluocortolone; rectal, topical
1.3
6.3
461
3014
JFF23
NOMESCO Finland
Transversostomy
6.1
6.2
16
22
KWW96
NOMESCO Finland
Other reoperation in urological surgery
33.5
6.2
8
*
U28
ICPC
Limited function/disability (U)
3.4
6.2
28
69
UKD02
NOMESCO Finland
Urethroscopy
4.2
6.2
22
44
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.6
6.1
71
1042
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
6.1
121
606
J01MA01
ATC
ofloxacin; systemic
1.4
6.1
251
1495
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
5.0
6.0
18
30
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.4
6.0
24
496
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.1
6.0
64
256
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000850) Epithelial cells [#/volume] in Urine
4674
14847
2.33
307.65
3.0
2.5
e6/l
2.6
2.7
0.50
4186
12911
(3018095) Leukocytes [#/volume] in Urine
6781
24260
2.27
307.65
4.6
3.5
e6/l
82.5
95.0
0.46
5579
17874
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
594
492
7.63
307.65
2.3
1.3
ug/l
23.1
19.6
0.56
581
480
(4035726)
1735
2050
5.70
307.65
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
6502
21697
2.45
307.65
4.1
3.1
e6/l
136.3
112.7
0.32
5420
16782
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
11784
51974
2.69
307.65
9.9
5.7
u/l
81.9
75.9
16.74
11388
48380
(36304419) Bacteria [Presence] in Urine
5543
18691
2.27
307.65
3.9
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
5837
19715
2.31
307.65
3.9
3.0
e6/l
0.3
0.5
5.77
4740
14780
(40768800) Prostate Pathology biopsy report
4128
1040
32.85
307.65
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7621
29874
2.11
307.65
4.4
3.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
7530
25841
2.54
307.65
4.0
3.2
—
0.7
—
0
8
(3017446) Testosterone [Moles/volume] in Serum or Plasma
4289
8876
3.71
307.65
2.3
2.2
nmol/l
8.4
15.0
307.65
3710
7886
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
12648
57108
3.06
307.65
11.7
3.8
ug/l
9.4
2.2
25.40
11306
51570
(3002256) Pathology report gross observation
2434
5365
3.11
307.65
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
6135
18872
2.65
307.65
2.3
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8143
32127
2.17
307.65
4.8
2.7
ug/l
1.0
0.7
43.28
6429
21596
(3026008) Bacteria identified in Urine by Culture
4878
14755
2.50
307.65
3.5
2.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
5232
18791
2.06
307.65
4.6
2.1
mmol/l
2.3
2.3
5.71
4683
15791
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
8224
33814
2.05
307.65
7.8
4.2
umol/l
11.6
13.5
35.18
7917
31912
(3037467) Urinalysis macro (dipstick) panel - Urine
10266
46009
2.11
307.65
4.7
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10345
45651
2.19
307.65
7.9
3.7
%
15.3
24.0
307.65
7239
21690
(3026782) Osmolality of Urine
4314
13690
2.29
307.65
3.3
2.6
mosm/kgh2o
606.9
590.3
5.07
3820
11534
(3031040) Bacteria [#/volume] in Urine by Automated count
10951
41512
3.16
307.65
5.2
3.7
e6/l
279.7
589.7
0.74
214
782
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1665
3605
3.04
306.58
4.0
1.6
ug/l
22.9
8.7
1.54
1370
2736
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
406
201
12.64
306.40
8.8
1.1
u/l
1534.8
2.2
0.53
132
25
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3588
11418
2.20
303.97
3.8
2.7
e6/l
0.6
0.8
3.09
2260
6371
(3044640) Blood type and Crossmatch panel - Blood
5107
19572
1.89
252.80
2.7
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3620
12369
2.03
248.51
3.5
2.6
e6/l
0.8
0.9
2.40
2281
7264
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
391
277
8.82
239.34
2.8
1.7
nmol/l
6.4
5.3
0.25
385
268
(3049717) Cytology report of Urine Cyto stain
1379
3147
2.84
229.21
3.0
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7377
32878
1.72
209.19
8.2
6.6
mmol/l
1.2
1.2
2.06
6128
27748
(3013650) Neutrophils [#/volume] in Blood by Automated count
7846
36132
1.67
189.85
9.7
6.5
e9/l
4.3
4.5
8.00
6870
30957
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6750
29926
1.68
187.98
7.1
6.3
mmol/l
1.2
1.2
4.56
6138
26824
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2412
7788
2.06
186.60
5.0
2.8
u/l
252.1
241.1
1.84
2312
7256
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
510
675
4.74
181.48
6.6
2.2
u/ml
471.3
979.1
0.21
499
661
(3024561) Albumin [Mass/volume] in Serum or Plasma
6408
28472
1.64
171.88
5.3
4.3
g/l
34.7
35.2
10.80
5934
26199
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3905
15174
1.77
171.28
2.6
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
8858
43274
1.60
154.79
5.0
5.0
mmol/l
6.9
7.0
10.73
8426
40659
(3032080) INR in Blood by Coagulation assay
6915
32195
1.57
144.24
10.3
11.2
inr
1.3
1.4
4.74
2070
8794
(3003694) ABO and Rh group [Type] in Blood
4146
17243
1.64
136.21
1.3
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
193
109
10.93
135.63
9.4
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1425
4296
2.13
128.54
3.7
2.6
e6/l
0.2
0.3
2.48
1405
4231
(3018418) pH of Serum or Plasma
4306
18514
1.58
120.65
5.3
3.7
ph
7.4
7.4
0.70
979
3443
(3023368) Bacteria identified in Blood by Culture
4823
21323
1.56
119.58
4.8
4.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2712
10374
1.72
119.48
3.7
2.0
mmol/l
2.5
2.4
15.64
2391
8756
(3009261) Glucose [Presence] in Urine by Test strip
6772
33002
1.45
99.58
3.9
3.3
estimate
0.0
0.0
2.50
1521
5356
(3021601) Nitrite [Presence] in Urine by Test strip
6679
32541
1.45
97.65
5.0
4.3
estimate
0.0
0.0
0.50
1593
5827
(40758558) Short blood count panel - Blood
3564
15298
1.55
96.57
7.7
5.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3881
17000
1.53
95.82
3.5
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
6693
32742
1.44
94.74
3.8
3.2
estimate
0.0
0.0
0.31
1554
5603
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
12068
66199
1.54
92.62
19.6
13.1
ml/min/173m2
76.1
77.5
11.68
10664
54148
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
576
1337
2.69
91.01
3.1
2.0
u/ml
875.4
107.6
1.96
485
1107
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
12453
68922
1.56
89.70
18.5
14.2
mg/l
29.6
27.2
10.31
10468
54866
(3019550) Sodium [Moles/volume] in Serum or Plasma
13137
73992
1.60
81.40
21.6
17.4
mmol/l
139.6
139.8
16.70
12864
72078
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2568
10634
1.57
79.29
3.5
3.0
mmol/l
0.8
0.8
3.58
2441
9834
(3033658) Prothrombin time (PT) actual/Normal
3776
17001
1.47
78.82
4.2
4.0
%
85.6
81.7
16.91
3710
16612
(3023103) Potassium [Moles/volume] in Serum or Plasma
13151
74204
1.59
78.79
21.9
17.4
mmol/l
4.0
4.0
4.72
12861
72212
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1908
7391
1.66
77.06
3.7
3.4
—
—
—
0
0
(3013512) EKG study
4725
22332
1.42
75.60
4.2
4.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1451
5255
1.76
74.62
3.9
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5305
25650
1.40
74.25
4.1
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1401
5160
1.72
67.63
5.1
3.4
mmol/l
1.2
1.2
1.73
1233
4450
(3002030) Lymphocytes/100 leukocytes in Blood
6224
31320
1.36
65.86
5.8
5.8
%
24.6
26.1
17.34
5747
28944
(42870588) Differential panel, method unspecified - Blood
4639
22267
1.39
65.69
5.5
5.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
6083
30573
1.36
64.40
5.9
6.0
%
9.2
9.1
0.57
5655
28418
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3763
17479
1.42
64.09
2.1
2.2
mg/l
3.0
2.9
1.22
3187
14781
(3006504) Eosinophils/100 leukocytes in Blood
6046
30405
1.35
63.46
5.6
5.7
%
2.9
3.0
3.26
5607
28174
(3029937) Albumin [Presence] in Urine by Test strip
3901
18293
1.41
62.69
4.1
3.6
estimate
0.0
0.0
0.21
1443
5353
(3019225) pH of Specimen
1649
6500
1.62
61.24
5.0
3.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
13162
75121
1.51
60.60
24.3
16.6
umol/l
91.0
89.4
3.82
13157
75087
(3022096) Basophils/100 leukocytes in Blood
5868
29535
1.35
60.23
5.6
5.8
%
0.6
0.7
5.70
5446
27415
(40768795) Lymph node Pathology biopsy report
129
130
6.10
60.19
1.2
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
6077
30899
1.33
57.35
5.5
5.7
%
59.6
58.4
9.58
5642
28737
(40761511) CBC panel - Blood by Automated count
12659
71890
1.44
56.77
18.9
13.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
2299
9923
1.49
56.66
7.1
7.7
mmol/l
104.8
104.5
1.67
2268
9647
(3021589) Normoblasts [#/volume] in Blood
5873
29764
1.33
56.37
12.0
9.0
e9/l
0.0
0.0
0.19
4897
24484
(3023323) Follitropin [Units/volume] in Serum or Plasma
211
396
3.28
47.79
2.8
1.3
iu/l
14.3
9.4
3.67
170
319
(3015736) pH of Urine
5054
25575
1.31
46.30
3.6
3.1
ph
5.8
5.4
2.05
36
18
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4858
24559
1.30
44.32
2.8
2.9
ug/l
244.4
182.5
13.54
4350
22482
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1107
4307
1.61
42.66
8.0
11.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12969
74784
1.39
42.15
12.4
9.4
u/l
27.1
29.1
12.60
12489
71748
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
284
685
2.56
41.70
1.3
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
315
809
2.41
40.66
2.9
1.9
u/ml
151.7
1319.4
0.85
284
728
(3019198) Lymphocytes [#/volume] in Blood
6385
33700
1.27
40.41
5.5
5.6
e9/l
1.7
1.8
2.32
5502
29310
(3001604) Monocytes [#/volume] in Blood
6218
32751
1.27
39.83
5.4
5.5
e9/l
0.6
0.6
1.71
5254
28003
(3006315) Basophils [#/volume] in Blood
6251
32967
1.27
39.50
5.4
5.5
e9/l
0.0
0.0
15.19
5298
28228
(3022145) Colonoscopy Study observation
1607
6906
1.47
39.38
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1476
6242
1.49
39.16
3.5
3.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
6419
33997
1.26
38.96
5.6
5.7
e9/l
0.2
0.2
9.28
5504
29478
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
55
31
10.87
38.77
7.3
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
13311
77314
1.40
38.42
28.7
20.4
e9/l
230.1
229.0
1.27
13027
74841
(3035941) MCH [Entitic mass]
13312
77346
1.40
37.98
28.6
20.3
pg
30.6
30.7
3.74
13161
75934
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
90
102
5.41
37.78
5.1
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
13313
77365
1.40
37.77
28.6
20.4
fl
91.8
91.6
5.23
13164
75945
(3026361) Erythrocytes [#/volume] in Blood
13313
77366
1.40
37.75
28.7
20.4
e12/l
4.5
4.6
206.11
12977
74567
(3010813) Leukocytes [#/volume] in Blood
13314
77375
1.40
37.72
28.7
20.4
e9/l
6.8
6.9
2.69
12987
74596
(3000963) Hemoglobin [Mass/volume] in Blood
13314
77377
1.40
37.68
28.9
20.5
g/l
135.2
141.0
279.56
13154
75958
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2569
12089
1.36
37.39
2.0
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4248
21501
1.29
36.74
2.6
2.4
u/l
59.1
61.5
1.35
3904
19831
(3017181) Myelocytes/100 leukocytes in Blood
1309
5494
1.50
35.89
3.4
3.8
%
1.3
0.8
4.84
446
1305
(3027945) Reticulocytes/100 erythrocytes in Blood
1982
9006
1.39
35.60
2.6
2.2
%
1.8
1.7
0.85
1735
7894
(1761482) Bacteria [#/volume] in Urine by Culture
593
2041
1.80
35.56
4.5
3.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2070
9494
1.38
35.13
6.3
6.7
mmol/l
1.0
1.0
0.73
1935
8859
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1582
6935
1.44
34.71
3.0
2.5
umol/l
8.7
9.6
0.85
1405
6154
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
86
102
5.17
34.54
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1539
6730
1.44
34.18
2.8
2.3
e9/l
67.7
68.1
0.14
1192
5140
(3004809) Band form neutrophils/100 leukocytes in Blood
322
921
2.16
32.56
3.4
3.0
%
1.8
1.4
0.78
230
686
(3022948) Iron [Moles/volume] in Serum or Plasma
2450
11686
1.33
32.06
2.6
2.7
umol/l
12.5
13.2
5.53
2254
10801
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2303
10893
1.34
31.87
2.6
2.7
g/l
2.2
2.2
3.98
2112
10057
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1276
5458
1.47
31.70
2.2
2.1
g/l
0.2
0.2
0.95
1176
4942
(3021440) Promyelocytes/100 leukocytes in Blood
1237
5261
1.47
31.63
3.5
3.8
%
0.2
0.1
2.44
416
1213
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2169
10260
1.34
29.82
2.7
2.8
%
23.0
23.8
1.79
1807
8683
(3002179) Metamyelocytes/100 leukocytes in Blood
1171
5004
1.46
29.16
3.3
3.6
%
1.1
0.5
3.58
317
964
(3044889) 12 lead EKG panel
9216
51698
1.22
28.87
4.2
4.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
9904
55983
1.23
28.71
24.1
16.8
%
13.8
13.7
15.49
9766
54587
(3021960) Folate [Moles/volume] in Serum or Plasma
3406
17195
1.27
28.69
1.6
1.6
nmol/l
18.4
18.8
1.11
2905
14804
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1068
4500
1.48
28.53
1.6
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
8917
49891
1.22
28.42
3.9
3.9
mm/h
14.2
11.4
38.82
8067
45940
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4170
21598
1.25
28.06
3.6
2.8
u/l
35.2
37.5
0.83
3940
20302
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1011
4241
1.49
27.58
8.8
10.8
mmol/l
23.8
24.3
4.90
958
3855
(3016502) Oxygen saturation in Arterial blood
1866
8745
1.34
27.10
7.1
8.4
%
95.7
95.0
4.77
1768
8442
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
810
3258
1.55
26.88
2.0
2.0
ug/l
3.6
2.1
1.21
701
2892
(3025159) Blasts/100 leukocytes in Blood
1150
4974
1.44
26.83
3.5
3.8
%
0.0
0.2
0.86
353
1045
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2517
12333
1.29
26.60
2.0
2.1
s
30.3
30.4
0.49
2446
11980
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1685
7826
1.35
25.88
7.6
9.1
g/l
121.4
125.4
11.52
1608
7567
(3014111) Lactate [Moles/volume] in Serum or Plasma
1519
6975
1.37
25.05
7.0
8.0
mmol/l
1.4
1.5
1.54
1463
6697
(3003396) Base excess in Arterial blood by calculation
1992
9543
1.32
24.70
7.0
8.1
mmol/l
0.5
1.1
8.42
1544
7421
(21494755) Public health laboratory ask at order entry panel
523
5055
0.62
24.34
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
880
3693
1.48
23.91
4.1
3.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1984
9547
1.31
23.76
6.9
8.1
kpa
12.3
11.5
10.32
1868
9114
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1983
9554
1.31
23.51
7.0
8.1
kpa
5.1
5.0
1.89
1863
9123
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
732
2990
1.52
22.63
2.0
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
191
528
2.22
21.13
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
673
2747
1.52
20.89
1.9
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
1427
6683
1.33
20.52
8.6
9.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
69
108
3.91
20.38
5.8
1.1
u/ml
36.3
146.4
0.48
23
15
(3009542) Hematocrit [Volume Fraction] of Blood
10664
61482
1.20
20.34
20.4
15.4
%
39.1
40.7
36.93
6759
41094
(3022621) pH of Urine by Test strip
986
4363
1.41
20.18
3.0
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4565
24507
1.20
19.92
3.0
3.2
ng/l
1868.0
1680.2
1.28
3940
21253
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
660
2721
1.50
19.55
2.9
3.2
u/ml
0.4
0.3
0.78
370
1602
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
995
4441
1.39
19.36
1.8
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
248
791
1.93
18.95
1.5
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
279
934
1.84
18.44
1.5
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1003
4541
1.37
17.90
6.5
8.5
mmol/l
24.4
24.6
0.93
997
4490
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1279
6048
1.32
17.10
3.2
2.5
ml/min/173m2
64.5
63.0
0.60
506
2297
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5534
30508
1.17
16.86
4.0
3.9
ng/l
53.9
95.4
3.48
4468
23252
(3008757) Leukocyte morphology finding [Identifier] in Blood
213
674
1.94
16.71
4.0
3.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
198
611
1.99
16.67
3.2
3.0
%
59.7
62.5
0.74
116
392
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1871
9318
1.26
16.67
4.6
4.9
%
31.2
31.4
0.33
1227
6494
(3020630) Protein [Mass/volume] in Serum or Plasma
1316
6275
1.31
16.56
2.7
1.7
g/l
65.8
67.0
6.57
1193
5719
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
111
270
2.52
16.33
1.5
1.3
mg/l
4.3
4.2
0.09
102
262
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
179
537
2.05
16.28
1.5
1.2
u/l
97.7
54.7
2.04
128
326
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
19
0
+∞
16.18
1.1
0.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
24
15
9.78
15.96
8.4
4.3
umol/l
0.3
0.3
—
24
8
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1176
5599
1.31
14.93
2.4
2.4
u/l
35.2
51.7
1.09
981
4775
(3020779) Urea [Moles/volume] in Serum or Plasma
1555
7674
1.26
14.89
7.2
8.1
mmol/l
11.4
11.2
0.54
1478
7272
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
836
3790
1.37
14.79
1.7
1.6
g/l
1.6
1.5
2.82
713
3226
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1691
8437
1.25
14.73
1.9
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1098
5200
1.31
14.48
9.0
10.5
%
0.6
0.7
13.92
1089
5163
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1191
9149
0.78
14.36
1.8
1.9
%
1.6
1.6
0.51
994
7864
(3007930) Methemoglobin/Hemoglobin.total in Blood
764
3434
1.38
14.26
4.4
5.3
%
0.9
0.9
0.40
699
3251
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
26
6.58
14.17
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
401
1594
1.55
14.13
1.6
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
396
1580
1.54
13.74
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
305
1147
1.64
13.55
1.7
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
771
3501
1.36
13.51
4.4
5.2
%
1.6
1.7
2.20
703
3317
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1096
5238
1.30
13.51
8.9
10.3
%
1.2
1.4
6.57
1088
5197
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
386
1542
1.54
13.33
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
223
774
1.77
13.25
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5488
30629
1.15
13.15
2.0
2.0
pmol/l
93.0
91.8
1.08
3163
17565
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
96
244
2.41
13.00
3.5
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2746
14550
1.19
12.93
1.8
1.8
nmol/l
1128.1
1130.2
0.04
2018
11105
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4232
23228
1.16
12.73
2.0
2.1
nmol/l
78.3
75.3
8.98
3670
20492
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
913
4292
1.32
12.70
1.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1672
8482
1.23
12.42
1.9
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2953
15796
1.18
12.35
3.8
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
415
1717
1.49
12.21
2.2
1.4
u/l
7.6
6.1
2.87
336
1388
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
85
211
2.47
12.12
2.0
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1088
5274
1.28
12.02
3.6
3.6
mmol/l
1.5
1.6
0.09
780
3801
(3012501) Base excess in Blood by calculation
431
1803
1.47
12.01
4.1
4.6
mmol/l
2.2
2.4
0.73
277
1187
(3013290) Carbon dioxide [Partial pressure] in Blood
431
1804
1.47
11.98
4.1
4.6
kpa
4.9
5.0
1.19
424
1754
(3019150) Specific gravity of Urine by Refractometry
2824
15094
1.17
11.87
4.3
3.6
kg/l
1.0
1.0
0.53
462
2181
(3035637) Corticotropin [Mass/volume] in Plasma
153
489
1.92
11.82
1.7
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
588
2613
1.39
11.80
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
1119
5463
1.27
11.67
3.7
3.6
ph
7.4
7.4
0.04
164
667
(3027315) Oxygen [Partial pressure] in Blood
431
1814
1.46
11.66
4.1
4.6
kpa
8.4
8.4
0.21
424
1763
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1134
5546
1.27
11.65
3.7
3.6
kpa
5.1
5.1
0.20
1040
5118
(1616796) Gas panel - Central venous blood
438
1851
1.46
11.61
3.8
4.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
116
338
2.10
11.52
1.3
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
83
210
2.42
11.41
2.0
1.4
—
—
—
0
0
(3010421) pH of Blood
476
2052
1.43
11.36
4.0
4.6
ph
7.4
7.4
0.47
426
1755
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
108
308
2.15
11.33
1.9
1.5
u/l
8.3
5.5
0.89
55
132
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
83
211
2.41
11.30
2.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
51
100
3.12
11.13
1.5
3.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
51
100
3.12
11.13
3.1
6.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
427
1813
1.45
11.07
5.6
7.3
mmol/l
105.0
105.1
0.21
369
1665
(3039000) Anion gap in Blood
427
1813
1.45
11.07
5.6
7.3
mmol/l
11.1
11.5
2.00
369
1665
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
102
287
2.18
11.06
1.8
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
564
2519
1.38
11.00
5.1
6.5
mmol/l
1.3
1.4
0.64
473
2268
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
97
270
2.20
10.81
1.2
1.1
u/l
20.1
23.9
0.40
60
205
(40767503) Oxygen content in Capillary blood by calculation
409
1734
1.45
10.70
2.5
2.7
%
16.1
16.8
2.70
234
952
(3037756) Immunofixation for Serum or Plasma
372
1550
1.48
10.63
1.5
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
96
270
2.18
10.45
1.2
1.1
u/l
68.9
92.5
2.31
64
216
(3004588) Protein electrophoresis panel - Serum or Plasma
1085
5354
1.26
10.34
2.2
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
540
2421
1.37
10.32
2.8
1.6
ratio
3.7
2.6
0.42
43
189
(3045414) Leukocytes [Presence] in Urine
630
2898
1.34
10.22
2.1
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
370
1554
1.46
10.18
1.7
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
54
116
2.85
10.17
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
471
2074
1.40
10.03
3.8
3.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
439
1910
1.42
10.01
2.8
3.0
kpa
7.8
7.9
0.21
410
1776
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
549
2496
1.36
9.63
2.9
1.6
mg/l
72.3
39.4
0.71
422
1996
(3000764) Benzodiazepines [Presence] in Urine
111
1254
0.54
9.57
1.4
2.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
549
2501
1.35
9.52
2.9
1.6
mg/l
66.2
53.9
0.62
419
2000
(40760892) CBC W Ordered Manual Differential panel - Blood
2554
13762
1.16
9.46
4.3
4.3
—
—
—
0
0
(4034850)
291
2603
0.68
9.46
13.5
10.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
113
1264
0.54
9.42
1.5
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
12
384
0.19
9.41
12.8
12.5
nmol/l
1021.9
801.1
0.61
12
364
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
437
1922
1.40
9.40
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
113
1262
0.54
9.38
1.4
2.2
—
—
—
0
0
(3012544) pH of Venous blood
1580
8196
1.20
9.26
4.1
4.1
ph
7.4
7.4
—
8
46
(3027944) Amphetamines [Presence] in Urine
109
1225
0.54
9.25
1.4
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
386
1669
1.42
9.15
2.8
2.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
339
1434
1.45
9.04
2.6
2.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
787
3800
1.28
9.01
4.2
4.5
mmol/l
23.7
23.9
0.93
703
3347
(3016879) Cocaine [Presence] in Urine
106
1191
0.54
9.00
1.4
2.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
32
53
3.69
8.96
1.4
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
122
399
1.87
8.93
2.5
2.2
e9/l
1.0
1.0
0.00
67
213
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
188
699
1.65
8.90
2.4
2.9
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
92
273
2.06
8.84
2.7
2.3
e9/l
0.1
0.1
2.07
86
265
(3024522) Salmonella sp identified in Specimen by Organism specific culture
193
726
1.63
8.75
1.5
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1503
7810
1.19
8.64
4.1
4.1
mmol/l
1.6
1.7
0.70
1208
6329
(40760888) Immunoglobulin light chains.free panel - Serum
414
1835
1.39
8.55
2.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
758
3682
1.27
8.29
2.6
2.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
189
720
1.61
8.18
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
189
720
1.61
8.18
1.5
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
287
1200
1.47
8.17
4.7
7.0
iu/ml
4534.1
974.0
0.44
37
204
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
5
17.11
8.16
1.0
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1497
7827
1.19
8.01
4.1
4.1
kpa
5.8
5.8
1.82
1466
7594
(3012441) Differential panel - Pleural fluid
207
811
1.57
7.98
1.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
565
2656
1.31
7.96
2.5
2.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
190
731
1.59
7.91
1.5
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2024
10858
1.16
7.86
2.0
2.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
194
752
1.58
7.84
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
187
719
1.60
7.82
1.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
198
772
1.57
7.81
1.6
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
257
1063
1.48
7.75
1.5
1.5
g/l
32.0
30.9
0.58
213
945
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
279
1174
1.46
7.72
3.2
3.4
%
59.5
59.0
0.23
279
1174
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
11722
69586
1.12
7.65
5.0
5.0
mmol/l
6.1
6.2
8.15
10372
63345
(1175426) CD3 cells/100 lymphocytes in Blood
92
289
1.95
7.64
1.8
2.1
%
68.1
71.3
1.11
85
272
(40768441) Liver Pathology biopsy report
78
231
2.07
7.60
1.3
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
691
3356
1.27
7.59
3.9
3.9
mmol/l
24.5
24.6
0.24
630
3091
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
196
769
1.56
7.54
1.5
1.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
28
48
3.57
7.53
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
85
963
0.54
7.51
1.5
2.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
20
26
4.70
7.48
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
184
714
1.58
7.43
1.4
1.3
u/l
525.3
461.3
0.14
171
672
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
422
1926
1.35
7.32
1.8
2.3
%
91.3
85.6
6.11
405
1815
(3045788) Cell count panel - Pleural fluid
184
719
1.57
7.22
1.6
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
933
4718
1.22
7.15
2.5
1.8
nmol/l
367.4
359.2
0.50
868
4296
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
345
2848
0.73
7.10
1.4
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
169
651
1.59
7.06
1.7
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10206
60230
1.10
7.03
3.7
3.7
mu/l
2.5
2.2
0.49
8894
54130
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
420
1929
1.34
7.01
1.9
2.5
g/l
3.7
3.6
0.43
399
1846
(3036782) Glucose [Moles/volume] in Pleural fluid
183
721
1.56
6.95
1.4
1.4
mmol/l
6.3
6.5
0.43
155
660
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
288
1253
1.41
6.72
1.8
2.0
mmol/l
1.9
1.8
0.31
281
1222
(40761539) Cells [Type] in Urine sediment by Light microscopy
60
169
2.17
6.67
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
799
4008
1.23
6.64
3.9
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
381
3066
0.75
6.61
1.4
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
117
417
1.72
6.60
1.5
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
87
283
1.88
6.59
1.8
2.1
%
22.7
16.7
1.63
29
113
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
115
409
1.72
6.54
1.5
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
375
1714
1.34
6.50
2.1
2.6
%
202.4
198.3
0.37
361
1626
(21494815) CD4 cells/100 lymphocytes in Specimen
110
388
1.74
6.44
1.9
2.3
%
39.3
44.2
0.48
20
51
(3009466) Valproate [Moles/volume] in Serum or Plasma
124
1218
0.62
6.44
3.4
4.8
umol/l
323.3
351.9
1.53
94
1024
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
81
261
1.90
6.33
1.8
2.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
91
305
1.83
6.31
1.8
1.2
u/l
110.7
103.4
0.17
79
255
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
157
612
1.57
6.29
1.8
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
145
555
1.60
6.27
1.8
1.9
u/field
2.0
1.4
0.56
63
230
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
112
401
1.71
6.24
1.4
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
56
158
2.17
6.23
1.8
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
852
4337
1.21
6.14
2.7
3.0
e9/l
4.2
4.2
0.06
627
3199
(3011288) Drugs identified in Urine by Screen method
72
804
0.54
6.14
2.0
3.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
483
2309
1.29
6.10
1.8
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
262
1142
1.41
6.10
6.3
6.2
mg/l
11.9
11.5
0.57
245
1051
(3028308) Erythrocytes [#/volume] in Pleural fluid
204
849
1.47
6.07
1.5
1.5
e6/l
57303.6
64981.5
0.15
126
522
(3023199) Leukocytes [#/volume] in Pleural fluid
222
942
1.45
5.99
1.5
1.5
e6/l
2081.6
3892.0
0.85
157
692
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
394
3112
0.77
5.99
1.6
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
86
289
1.82
5.95
1.8
1.2
u/l
36.1
26.0
0.53
74
240
(3043410) Blood group antigens tested for on Red Blood Cells
59
174
2.07
5.90
2.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
690
5102
0.82
5.90
1.9
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1627
8771
1.15
5.87
1.3
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
217
924
1.44
5.77
2.3
3.0
u/ml
582.3
10599.9
0.49
16
54
(3015235) Bicarbonate [Moles/volume] in Capillary blood
481
2317
1.28
5.74
3.1
3.2
mmol/l
24.5
24.5
0.00
423
2056
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
145
568
1.56
5.73
1.3
1.3
u/l
15.2
13.5
0.24
132
526
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
45
120
2.29
5.73
2.0
1.4
u/l
42.4
34.9
0.12
39
107
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
286
1280
1.37
5.72
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
690
3466
1.23
5.70
1.3
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2185
12032
1.13
5.68
27.5
29.1
inr
1.5
1.5
0.53
343
1587
(3028707) Methadone [Presence] in Urine by Screen method
46
574
0.49
5.63
1.8
3.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
211
900
1.44
5.57
1.9
2.2
mg/l
24.9
26.9
0.15
51
251
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1366
9487
0.87
5.56
1.2
1.2
iu/ml
31.3
43.8
1.92
377
2843
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
109
401
1.66
5.56
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
18
28
3.93
5.53
2.4
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
46
126
2.23
5.53
1.8
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7657
44846
1.08
5.50
3.3
3.1
u/l
58.0
56.8
0.45
6993
41377
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
223
964
1.42
5.48
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
401
1901
1.30
5.44
2.2
2.3
g/l
127.2
134.3
5.27
305
1398
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
103
377
1.67
5.37
1.7
1.8
u/field
2.5
2.9
0.19
71
273
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
253
1127
1.38
5.25
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
98
357
1.68
5.21
2.6
2.1
e6/l
510.4
690.9
1.95
45
153
(3000012) Reticulocyte production index
111
418
1.63
5.20
1.3
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
143
572
1.53
5.20
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
4453
28883
0.92
5.20
4.0
4.2
mg/mmol
9.1
9.4
0.12
2924
19966
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
75
253
1.81
5.18
1.7
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2538
14170
1.11
5.16
1.6
1.8
mg/l
1.7
1.3
3.32
1981
11069
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
62
197
1.93
5.13
1.5
1.8
u/ml
2183.5
13883.0
—
6
32
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
233
1029
1.39
5.10
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
122
473
1.58
5.09
1.5
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
245
2017
0.74
5.07
1.5
1.8
mg/l
3.9
4.2
0.15
178
1425
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
228
1005
1.39
5.05
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
420
3217
0.79
5.03
1.2
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
15
283
0.32
4.99
2.2
2.7
nmol/l
124.4
137.2
0.27
15
245
(21494434) Karyotype in Bone marrow
141
570
1.51
4.91
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
234
1042
1.38
4.90
2.4
2.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
83
296
1.72
4.79
2.8
2.0
e6/l
576.9
460.1
0.47
71
255
(3036489) Thrombin time
491
2428
1.24
4.76
1.7
2.1
s
21.8
21.9
0.16
448
2153
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
396
1910
1.27
4.75
3.0
2.8
mg/l
1.7
1.8
0.24
356
1701
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
506
2512
1.24
4.74
2.3
1.6
g/l
1.3
0.5
3.26
428
2163
(40768793) Breast Pathology biopsy report
20
38
3.22
4.73
1.1
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
4288
27770
0.92
4.73
3.1
3.4
mmol/l
8.4
8.6
2.94
3432
23419
(3045424) Erythrocytes [Presence] in Urine
249
1127
1.35
4.72
1.5
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
11
9
7.47
4.68
4.5
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
121
479
1.55
4.66
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1216
8408
0.87
4.65
2.4
2.5
ug/l
7.2
9.5
3.12
1043
7507
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
866
4533
1.18
4.65
4.3
4.9
ng/l
107.8
108.8
0.09
747
3942
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
36
454
0.48
4.63
5.1
6.4
u/ml
32.2
512.2
—
6
108
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
518
3841
0.82
4.62
1.8
1.8
nmol/l
41.3
43.0
0.98
503
3703
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2826
15949
1.10
4.61
1.8
1.7
pmol/l
26473584.9
31986729.7
0.23
2274
13165
(3005719) IgG [Mass/volume] in Serum or Plasma
842
4401
1.18
4.60
2.7
2.1
g/l
10.7
11.3
2.43
760
4000
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
29
394
0.45
4.59
1.2
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
283
1313
1.32
4.57
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
4221
27311
0.92
4.51
3.2
3.4
mg/l
313.0
253.6
0.46
2792
18993
(3003888) Timothy IgE Ab [Units/volume] in Serum
65
677
0.58
4.43
1.0
1.1
u/ml
6.4
3.9
0.29
26
319
(3038515) Glucose [Moles/volume] in Venous blood
375
1816
1.27
4.39
3.6
3.3
mmol/l
7.3
8.0
5.80
366
1777
(3007853) Bacteria identified in Skin by Aerobe culture
1550
8493
1.13
4.37
1.7
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1057
5648
1.15
4.36
1.6
1.6
—
—
—
0
0
(4038314)
13
19
4.18
4.32
1.2
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
22
323
0.41
4.27
15.7
12.9
mmol/l
0.6
0.7
0.37
22
291
(3008037) Lactate [Moles/volume] in Venous blood
392
1916
1.26
4.26
3.6
3.2
mmol/l
1.6
1.7
0.95
383
1871
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
239
1920
0.76
4.24
1.3
1.5
nmol/l
1.0
0.8
1.86
204
1584
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
52
167
1.90
4.24
1.4
1.2
u/l
11.4
11.0
0.05
44
111
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
85
317
1.64
4.22
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
85
317
1.64
4.22
1.5
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
454
3376
0.82
4.20
1.3
1.3
u/ml
383.9
304.5
0.52
423
3159
(3041354) Potassium [Moles/volume] in Venous blood
234
1071
1.34
4.18
2.7
2.4
mmol/l
4.1
4.1
0.23
228
1062
(3035285) Chloride [Moles/volume] in Venous blood
234
1071
1.34
4.18
2.7
2.4
mmol/l
105.8
105.8
0.01
228
1061
(3037121) Protein [Mass/volume] in Urine
458
2284
1.23
4.16
2.9
2.9
g/l
0.3
0.4
0.71
222
1034
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
588
3008
1.20
4.14
2.0
1.4
g/l
7.4
7.4
0.31
427
2263
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
588
3008
1.20
4.14
2.0
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
586
2997
1.20
4.14
2.0
1.4
g/l
4.0
4.0
0.04
412
2178
(3003338) MCHC [Mass/volume]
9302
58351
0.93
4.13
25.7
18.2
g/l
333.4
334.6
26.97
9235
57835
(3033705) Calcium.ionized [Moles/volume] in Venous blood
230
1053
1.34
4.11
2.7
2.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
77
283
1.66
4.05
2.9
2.0
e9/l
0.3
0.2
0.37
70
254
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
135
566
1.46
4.02
1.4
1.4
u/l
12.2
13.6
1.75
129
543
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
93
869
0.65
4.02
1.4
1.2
nmol/l
1.4
1.4
0.07
83
790
(3024354) Oxygen [Partial pressure] in Venous blood
1189
6445
1.14
4.00
3.2
3.3
kpa
4.6
4.6
0.08
1161
6214
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
8
5
9.77
3.99
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
98
386
1.55
3.92
4.6
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
165
722
1.40
3.92
3.8
3.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
26
65
2.44
3.89
1.0
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
75
278
1.65
3.85
2.4
2.7
%
27.4
39.5
3.21
23
93
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
547
2806
1.20
3.77
2.0
1.5
g/l
10.2
10.5
0.74
455
2382
(3019832) Treponema pallidum Ab [Presence] in Serum
315
2404
0.80
3.76
1.5
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
163
1356
0.73
3.73
1.1
1.1
iu/ml
65.5
214.1
0.59
37
267
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
326
1587
1.26
3.72
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
352
2650
0.81
3.71
2.2
2.4
ug/min
97.7
132.7
0.85
195
1624
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
326
1588
1.26
3.70
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
81
310
1.60
3.68
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
81
310
1.60
3.68
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
11330
67830
1.08
3.65
6.3
6.7
mmol/mol
40.5
41.2
9.94
10224
62815
(3028026) IgM [Mass/volume] in Serum or Plasma
668
3498
1.17
3.64
2.1
1.5
g/l
1.2
1.1
0.53
594
3195
(3015171) Extractable nuclear Ab [Units/volume] in Serum
261
2027
0.78
3.63
1.1
1.2
u/ml
0.2
0.6
1.93
20
179
(4094501)
324
2453
0.80
3.61
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
54
186
1.78
3.61
2.3
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
67
654
0.62
3.58
1.0
1.1
u/ml
0.5
1.1
0.56
24
255
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1280
8668
0.89
3.53
1.2
1.2
u/ml
11.0
14.0
0.78
408
3237
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
82
763
0.65
3.53
1.0
1.1
u/ml
0.6
1.4
1.80
31
323
(3000475) Leukocytes [#/volume] in Synovial fluid
284
2174
0.79
3.51
1.6
1.6
e6/l
19458.1
15608.7
0.59
200
1610
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
48
161
1.82
3.50
3.5
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1038
5633
1.13
3.47
1.6
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
554
0.60
3.38
2.0
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
72
275
1.60
3.34
3.0
2.3
—
—
—
0
0
(1002224) Polysomnography panel
361
2673
0.82
3.28
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
48
496
0.59
3.28
1.0
1.1
u/ml
1.0
2.8
1.79
14
209
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
36
402
0.55
3.27
1.0
1.0
u/ml
0.3
0.4
—
9
105
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
22
56
2.40
3.21
1.5
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
260
1984
0.80
3.16
1.6
1.6
iu/ml
24.1
3.5
0.51
60
454
(3023430) Cat dander IgE Ab [Units/volume] in Serum
44
460
0.58
3.16
1.0
1.1
u/ml
1.0
2.5
0.89
12
183
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
540
2817
1.18
3.14
2.1
1.5
g/l
3.1
3.0
1.33
419
2230
(3010726) Horse dander IgE Ab [Units/volume] in Serum
60
578
0.63
3.09
1.0
1.1
u/ml
1.2
1.6
0.24
14
134
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
6
7.13
3.07
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
219
1045
1.28
3.02
4.7
4.2
—
—
—
0
0
(3004451) EKG impression Narrative
98
412
1.46
2.99
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
120
528
1.39
2.87
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
204
1579
0.79
2.85
1.5
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
84
741
0.69
2.83
1.2
1.1
iu/ml
3.5
1.8
—
7
25
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1312
7310
1.10
2.80
2.7
3.2
ng/l
232.7
252.2
0.72
1194
6712
(3008898) HLA-B27 [Presence]
184
1439
0.78
2.80
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
107
0.29
2.80
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1074
5922
1.12
2.80
4.5
5.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
17
41
2.53
2.78
6.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
15
212
0.43
2.78
8.0
6.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
73
658
0.68
2.77
1.9
2.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
447
2325
1.18
2.74
2.1
1.5
g/l
37.0
37.5
0.90
381
2014
(3051387) C reactive protein [Mass/volume] in Capillary blood
336
1704
1.21
2.73
3.3
3.3
mg/l
33.3
28.7
1.27
214
1129
(4198724)
13
193
0.41
2.72
1.3
2.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1184
7922
0.91
2.65
1.2
1.3
titre
430.4
462.1
0.27
200
1533
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
266
1982
0.82
2.65
1.5
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
25
74
2.06
2.65
1.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
99
428
1.41
2.65
3.4
3.8
—
—
—
0
0
(44806118)
161
754
1.31
2.61
1.4
1.6
—
—
—
0
0
(44790048)
161
755
1.31
2.59
1.4
1.6
—
—
—
0
0
(44790049)
161
755
1.31
2.59
1.4
1.6
—
—
—
0
0
(44790047)
161
755
1.31
2.59
1.4
1.6
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
14
3.93
2.57
1.7
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
101
441
1.40
2.57
2.7
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1008
5569
1.11
2.56
6.6
7.7
mmol/l
24.4
24.4
0.15
926
5228
(3019977) pH of Arterial blood
117
525
1.36
2.53
2.4
2.3
ph
7.4
7.4
0.35
44
182
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
434
2270
1.17
2.52
2.2
1.5
g/l
0.1
0.0
0.93
399
2071
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
120
0.36
2.50
2.0
3.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
34
115
1.81
2.50
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
142
658
1.32
2.50
1.3
1.3
nmol/l
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
575
3075
1.15
2.49
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1448
8157
1.09
2.48
1.4
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
161
760
1.30
2.48
1.4
1.2
nmol/l
0.6
2.0
0.49
154
736
(3047189) Immunofixation for 24 hour Urine
75
312
1.47
2.47
1.9
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
136
1085
0.76
2.46
1.4
1.7
g/l
1.0
1.0
0.06
103
816
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
23
69
2.04
2.38
3.4
1.6
u/l
42.7
131.5
—
6
28
(3023383) Lactate [Moles/volume] in Pleural fluid
55
216
1.56
2.37
1.3
1.4
mmol/l
3.8
3.7
0.05
47
194
(4211845)
84
361
1.42
2.36
4.0
2.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
160
762
1.28
2.33
1.4
1.2
nmol/l
0.1
0.2
0.71
14
64
(3011897) Casein IgE Ab [Units/volume] in Serum
0
40
0.00
2.32
0.0
1.1
—
0.4
—
0
13
(43055442) Apixaban [Mass/volume] in Serum or Plasma
34
119
1.75
2.27
1.8
1.7
ug/l
85.1
116.4
1.08
28
96
(3023511) Choriogonadotropin [Units/volume] in Urine
6
7
5.23
2.26
1.3
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
13
3.76
2.25
1.8
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
77
658
0.71
2.24
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
29
97
1.83
2.24
1.4
1.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
86
720
0.73
2.21
1.0
1.0
ng/l
704.9
730.2
0.25
63
478
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
86
719
0.73
2.19
1.0
1.0
ng/l
36.4
41.0
0.63
64
484
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
734
4024
1.12
2.19
2.8
2.9
%
1.2
1.3
0.66
726
4005
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
86
718
0.73
2.18
1.0
1.0
ng/l
276.5
303.6
0.58
66
493
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
400
2110
1.16
2.14
2.2
1.5
g/l
0.0
0.0
0.80
366
1915
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
58
516
0.68
2.14
2.1
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
77
333
1.41
2.12
4.3
2.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
393
2073
1.16
2.11
2.2
1.5
g/l
0.0
0.0
0.00
363
1909
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
714
3920
1.12
2.09
2.8
2.9
%
0.6
0.7
1.08
677
3761
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2671
15499
1.06
2.09
3.9
4.1
ng/l
783.3
840.1
0.06
2291
13309
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
8
4.58
2.07
11.2
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
72
612
0.72
2.06
1.2
1.2
titre
74.7
166.0
2.02
17
106
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
54
220
1.50
2.03
1.3
1.3
ug/l
125.3
33.9
0.55
26
94
(3014271) Vancomycin [Susceptibility]
96
435
1.35
2.03
2.7
2.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
125
589
1.30
2.02
1.5
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
952
5319
1.10
2.00
3.5
3.5
g/l
127.1
132.8
10.62
929
5191
(3042733) HLA Ab [Presence] in Serum
35
340
0.63
1.99
5.2
5.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
14
176
0.49
1.98
2.2
2.5
—
133.6
—
0
25
(3003181) Sodium [Moles/volume] in Urine
220
1111
1.21
1.97
1.3
1.3
mmol/l
61.2
65.9
0.99
178
879
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
16
192
0.51
1.97
2.7
3.0
mg/l
6.2
7.0
0.41
11
161
(3044941) Cell count panel - Synovial fluid
179
1339
0.81
1.95
1.4
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
45
178
1.54
1.94
1.4
1.4
%
17.2
27.4
1.62
35
145
(3022475) Manganese [Moles/volume] in Blood
7
12
3.56
1.93
1.9
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
23
245
0.57
1.91
8.2
7.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
44
174
1.55
1.90
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
11983
72307
1.05
1.89
5.2
5.5
mmol/l
2.6
2.5
2.84
10700
66908
(3036603) Volume of Urine
93
425
1.34
1.88
2.1
1.4
ml
2162.8
2022.7
0.24
32
94
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
20
63
1.94
1.87
1.0
1.1
iu/ml
5.7
17.0
—
7
22
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
26
90
1.76
1.85
2.2
2.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
26
90
1.76
1.85
2.2
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
250
1800
0.85
1.83
1.5
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
90
724
0.76
1.83
1.1
1.1
au/ml
5.5
8.5
—
10
38
(3035880) pH of Pleural fluid
95
438
1.33
1.82
1.3
1.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
57
242
1.44
1.79
1.3
1.4
%
2.2
2.8
0.28
47
193
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
256
1829
0.85
1.73
1.7
1.9
mg/l
10.9
11.3
0.37
232
1713
(3024869) Neuronal Ab [Presence] in Serum
39
154
1.55
1.72
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
173
1279
0.82
1.72
1.1
1.1
u/ml
3.6
8.5
1.26
14
132
(3037692) Legionella sp identified in Specimen by Organism specific culture
56
239
1.43
1.72
1.2
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
3777
22255
1.05
1.67
3.0
2.7
umol/l
5641.7
5408.5
0.09
3186
19264
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
276
1448
1.17
1.66
2.1
1.2
u/l
39.8
23.5
1.20
236
1245
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
64
282
1.39
1.66
1.4
1.4
%
63.2
65.4
0.20
50
222
(3001556) Androgen free Index in Serum or Plasma
8
18
2.71
1.64
1.4
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
23
80
1.76
1.63
1.6
2.0
e6/l
12598.0
120.2
—
10
44
(3012565) Volume of 24 hour Urine
81
372
1.33
1.63
2.1
2.1
ml
1941.6
2047.9
0.37
64
322
(40763590) HLA-DQ beta [Type]
6
11
3.33
1.62
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
202
0.57
1.61
1.9
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
7629
45660
1.04
1.60
3.0
2.9
pmol/l
15.0
14.9
1.73
6642
40638
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
25
90
1.70
1.59
1.3
1.4
u/l
31.5
42.3
0.36
18
65
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
107
513
1.28
1.59
1.2
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
62
513
0.74
1.57
1.2
1.3
nmol/l
1.3
1.3
0.15
50
377
(46235355) HIV 1 and 2 tests - Meaningful Use set
1271
7272
1.07
1.56
1.6
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
69
561
0.75
1.56
1.1
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
33
129
1.56
1.55
1.8
2.1
%
8.7
8.8
0.02
28
114
(3048929) Epstein Barr virus Ab [Presence] in Serum
269
1419
1.16
1.53
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
31
289
0.65
1.53
1.1
1.0
—
—
—
0
0
(4010399)
819
5413
0.92
1.52
1.5
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
83
388
1.31
1.50
1.5
1.4
%
3.7
4.0
0.10
19
98
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
157
792
1.21
1.50
3.1
3.8
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
6
12
3.05
1.50
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
6
12
3.05
1.50
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
6
12
3.05
1.50
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
6
12
3.05
1.50
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
404
2761
0.89
1.47
4.6
4.9
mmol/l
3.9
4.0
0.69
373
2588
(3027135) IgG subclass 1 [Mass/volume] in Serum
85
665
0.78
1.46
1.3
1.4
g/l
7.2
7.0
0.21
53
455
(4062490)
85
665
0.78
1.46
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
139
695
1.22
1.46
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
193
1387
0.85
1.45
1.3
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
85
664
0.78
1.45
1.3
1.4
g/l
3.4
3.2
0.48
55
457
(3024139) IgG subclass 3 [Mass/volume] in Serum
85
664
0.78
1.45
1.3
1.4
g/l
0.5
0.4
0.51
56
459
(3000093) Morphology [Interpretation] in Blood Narrative
145
730
1.21
1.43
1.2
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
53
441
0.73
1.42
1.8
2.3
mmol/l
9.5
9.1
0.38
44
320
(3032057) Clostridioides difficile [Presence] in Stool
33
132
1.53
1.42
1.6
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
764
4305
1.09
1.41
3.8
3.5
mmol/l
24.9
25.0
0.35
738
4169
(4024509)
106
517
1.25
1.40
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11716
70807
1.04
1.40
4.7
4.9
mmol/l
4.4
4.3
10.08
10532
65842
(3038071) Oxygen [Partial pressure] in Mixed venous blood
33
297
0.68
1.40
8.4
7.8
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
12
139
0.53
1.39
1.3
1.7
—
76.1
—
0
16
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
94
720
0.80
1.37
1.1
1.1
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
10
27
2.26
1.37
1.2
1.6
u/field
1.6
0.8
—
5
14
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
27
104
1.59
1.37
1.4
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
101
493
1.25
1.34
1.3
1.2
mmol/l
2.2
2.1
0.21
95
459
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
429
2901
0.90
1.33
1.7
1.8
u/l
38.2
37.8
0.12
365
2487
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
708
3990
1.09
1.33
4.4
4.1
%
47.4
48.3
0.46
699
3937
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
49
1.87
1.32
3.7
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
213
1504
0.86
1.31
1.3
1.3
e6/l
43.3
18.8
0.36
157
1173
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
11276
68124
1.04
1.31
4.2
4.4
mmol/l
1.3
1.3
4.39
9963
62548
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
370
2520
0.89
1.31
1.4
1.4
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
25
96
1.59
1.29
1.3
1.3
%
22.1
28.2
0.36
16
65
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
29
116
1.53
1.27
1.4
1.4
%
9.6
7.9
0.23
15
50
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
26
240
0.66
1.27
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
214
1506
0.87
1.27
1.4
1.4
e6/l
505.2
1527.3
1.68
167
1242
(3040151) Glucose [Moles/volume] in Capillary blood
194
1017
1.17
1.26
5.9
14.2
mmol/l
7.1
7.7
2.36
166
829
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
154
1109
0.85
1.23
1.3
1.3
pmol/l
54.8
105.3
1.02
86
319
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
12
37
1.98
1.23
1.2
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
320
1740
1.13
1.23
1.4
1.5
ug/g
258.9
267.5
0.28
193
1059
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
141
1022
0.84
1.22
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
33
2.04
1.21
3.4
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1699
10860
0.95
1.20
1.2
1.2
u/ml
1.9
2.1
0.21
415
2915
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
203
1427
0.87
1.20
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1045
6003
1.07
1.20
2.2
2.5
ug/g
159.1
171.5
0.41
812
4831
(3002619) Bacteria identified in Specimen by Culture
33
138
1.46
1.20
1.2
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
65
1.69
1.18
1.3
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
65
1.69
1.18
1.3
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
65
1.69
1.18
1.3
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
260
1794
0.88
1.17
1.4
1.4
g/l
0.2
0.2
0.61
246
1709
(44813793)
43
356
0.74
1.17
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
242
0.68
1.16
1.1
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
37
313
0.72
1.15
1.2
1.3
%
65.4
60.3
0.41
31
275
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
197
1382
0.87
1.15
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
118
862
0.83
1.14
2.0
2.3
ml
697.7
696.2
0.01
67
580
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
22
85
1.58
1.13
3.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
205
1090
1.15
1.13
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
23
90
1.56
1.13
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
290
1579
1.12
1.12
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
1011
6542
0.94
1.11
1.5
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
138
713
1.18
1.10
1.7
1.9
g/24h
0.4
1.3
—
5
40
(3051593) INR in Capillary blood by Coagulation assay
94
468
1.23
1.10
12.4
10.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
340
1871
1.11
1.09
2.8
3.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
252
1732
0.89
1.09
1.3
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
41
337
0.74
1.08
8.7
7.8
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
40
330
0.74
1.08
1.1
1.2
ratio
1.1
1.1
0.31
12
102
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
423
2826
0.91
1.08
1.6
1.6
titre
112.9
272.7
2.65
14
111
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
413
2298
1.10
1.08
3.1
3.2
pmol/l
4.5
4.4
0.56
364
2056
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
194
0.66
1.07
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
119
0.56
1.06
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
61
290
1.29
1.06
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
38
168
1.38
1.06
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
116
593
1.20
1.05
1.3
1.4
mosm/kgh2o
279.5
280.6
0.16
88
448
(3005011) Chlamydia sp Ab [Titer] in Serum
5
69
0.44
1.04
1.6
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
20
2.14
1.04
1.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
115
833
0.84
1.03
2.5
2.2
—
0.4
—
0
7
(36660697) Celiac disease serology panel - Serum
595
3908
0.93
1.03
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
100
733
0.83
1.03
1.2
1.2
miu/ml
177.7
194.0
0.15
26
202
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
99
0.55
1.02
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
100
0.55
1.01
1.6
1.6
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
19
0.00
1.01
0.0
6.5
—
0.3
—
0
19
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11601
70238
1.03
1.01
4.7
4.8
mmol/l
1.3
1.3
22.19
10349
64858
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
34
149
1.39
1.00
11.4
10.8
mmol/l
5.4
5.9
0.38
34
149
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
271
1843
0.90
1.00
1.4
1.4
g/l
1.2
1.2
0.07
259
1757
(3010144) Erythrocytes [#/volume] in Synovial fluid
126
902
0.85
1.00
1.3
1.3
e6/l
152407.3
142858.7
0.06
89
637
(3036525) Urea [Moles/time] in 24 hour Urine
17
64
1.62
0.99
2.6
3.1
—
—
—
0
0
(3020891) Body temperature
539
3546
0.93
0.98
4.9
5.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
39
317
0.75
0.98
1.4
1.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
15
2.44
0.98
2.2
1.1
nmol/l
988.2
537.5
—
6
15
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
89
0.55
0.97
2.3
2.0
umol/l
15.0
16.8
—
8
89
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
55
262
1.28
0.96
2.5
2.4
—
—
—
0
0
(4306422)
125
891
0.86
0.95
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
86
433
1.21
0.94
1.7
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
59
285
1.26
0.93
2.4
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
59
285
1.26
0.93
2.4
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5792
34740
1.03
0.93
2.2
2.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
123
641
1.17
0.93
1.2
1.2
nmol/l
347.2
333.6
0.30
93
518
(37021550) Renin [Units/volume] in Plasma --upright
31
136
1.39
0.92
1.4
1.2
mu/l
54.6
63.8
0.15
24
96
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
219
1190
1.13
0.92
1.4
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
24
2.04
0.92
1.4
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
37
1.82
0.92
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1125
7203
0.95
0.90
1.5
1.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
43
339
0.77
0.89
2.2
2.4
umol/l
53.5
55.7
0.27
33
281
(3009445) Proteinase 3 Ab [Units/volume] in Serum
555
3626
0.93
0.87
1.6
1.5
u/ml
21.2
16.6
0.17
13
94
(3052592) Norovirus Ag [Presence] in Stool
30
133
1.38
0.86
1.1
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
421
2777
0.92
0.86
1.9
1.9
pmol/l
185.5
201.7
2.04
392
2618
(3003129) Base excess in Capillary blood by calculation
55
267
1.26
0.85
1.8
1.5
mmol/l
0.4
0.3
0.07
50
254
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
167
898
1.14
0.85
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
87
1.47
0.85
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
140
0.65
0.84
1.7
1.8
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
13
48
1.65
0.83
1.5
1.5
umol/l
0.7
0.6
—
6
42
(3002719) Hemoglobin [Mass/volume] in Urine
0
16
0.00
0.82
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
22
93
1.44
0.81
3.1
2.5
u/field
0.2
0.2
0.08
22
93
(3001964) Herpes simplex virus Ag [Presence] in Specimen
32
145
1.35
0.81
1.2
2.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
60
449
0.82
0.81
8.2
6.6
mmol/l
25.4
25.2
0.17
52
407
(3042951) Complement C1q Ab [Units/volume] in Serum
0
17
0.00
0.81
0.0
1.2
—
22.0
—
0
5
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
17
0.00
0.81
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
60
0.51
0.81
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
101
720
0.86
0.80
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
170
1167
0.89
0.79
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
154
829
1.14
0.79
2.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1007
6436
0.95
0.78
1.2
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
13
49
1.62
0.77
1.2
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
36
168
1.31
0.77
1.8
2.8
mmol/l
6.8
8.4
2.28
23
98
(3009677) Dengue virus Ab [Presence] in Serum
5
14
2.18
0.76
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
46
351
0.80
0.76
1.9
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
75
544
0.84
0.75
1.1
1.2
mmol/l
10.9
12.3
0.87
23
200
(3032868) Hemoglobin electrophoresis panel in Blood
6
67
0.55
0.75
1.3
1.5
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
11
40
1.68
0.74
1.0
1.1
mmol/l
5.9
6.0
0.03
11
25
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
180
1.29
0.74
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
84
435
1.18
0.73
2.0
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
329
2172
0.92
0.72
1.1
1.1
titre
179.4
245.0
—
9
58
(3036071) Salmonella sp Ab [Titer] in Serum
24
198
0.74
0.72
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
112
782
0.87
0.70
1.2
1.4
promille
1.3
1.5
0.88
94
596
(3028679) Herpes simplex virus Ab [Presence] in Serum
34
266
0.78
0.70
1.1
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
7
25
1.71
0.69
1.0
1.2
mmol/l
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
198
1094
1.11
0.68
1.6
1.5
%
62.4
62.4
0.00
130
735
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
7
26
1.64
0.66
2.4
1.5
%
0.9
1.8
—
7
26
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
199
1337
0.91
0.66
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
96
508
1.15
0.66
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
114
790
0.88
0.66
1.2
1.1
mmol/l
7.4
7.5
0.11
86
552
(3007566) Smooth muscle Ab [Titer] in Serum
257
1705
0.92
0.65
1.2
1.2
titre
120.0
103.5
0.12
24
163
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
23
103
1.36
0.65
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
78
407
1.17
0.64
1.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
28
130
1.32
0.64
2.8
1.6
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
31
241
0.78
0.63
1.1
1.3
nmol/l
211.7
143.8
0.56
23
181
(3024932) HLA-DR beta [Type]
39
295
0.81
0.63
1.2
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
68
352
1.18
0.62
2.3
6.9
mg/l
54.2
2220.4
1.34
50
261
(3016244) Insulin [Units/volume] in Serum or Plasma
28
220
0.78
0.62
2.5
3.2
mu/l
15.9
27.3
2.37
22
203
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
14
0.00
0.62
0.0
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
14
0.00
0.62
0.0
1.0
—
0.2
—
0
14
(3017704) Immunofixation for Urine
85
450
1.15
0.60
1.4
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
494
3187
0.94
0.59
4.1
4.6
mmol/l
1.4
1.4
0.59
479
3127
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
57
412
0.84
0.59
1.1
1.1
nmol/l
5.4
6.8
0.21
14
86
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
51
372
0.84
0.58
1.4
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
32
245
0.80
0.58
1.1
1.1
%
101.1
101.6
0.03
25
195
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
170
0.75
0.58
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
191
1065
1.10
0.58
2.2
2.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
153
844
1.11
0.58
1.8
1.3
pmol/l
237.1
256.5
0.49
111
609
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
77
407
1.16
0.56
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
40
297
0.82
0.56
1.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
59
1.45
0.56
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
154
852
1.10
0.56
1.5
1.4
%
26.5
24.9
0.24
94
580
(3007164) IgA [Mass/volume] in Serum or Plasma
1650
9799
1.03
0.55
1.5
1.3
g/l
2.7
3.0
4.08
1002
5947
(40762814) Titanium [Mass/volume] in Blood
24
189
0.77
0.55
2.0
2.4
ug/l
2.9
3.1
—
9
59
(3016750) Collection duration of Urine
86
598
0.88
0.55
2.0
2.1
min
515.4
498.6
1.07
53
445
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
67
352
1.16
0.54
1.3
1.2
—
—
—
0
0
(4212803)
6
60
0.61
0.54
1.3
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
119
809
0.90
0.53
1.5
2.1
titre
777.1
3461.7
—
7
48
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
33
162
1.24
0.53
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
356
2308
0.94
0.53
1.3
1.5
iu/ml
7.0
9.8
—
8
50
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
32
157
1.24
0.52
1.3
1.2
pmol/l
280.4
261.4
0.12
21
117
(3008116) Ketones [Moles/volume] in Urine by Test strip
32
157
1.24
0.52
1.2
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
17
76
1.37
0.51
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3242
19452
1.02
0.51
1.7
1.7
mmol/l
1.4
1.4
1.69
2563
16007
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
37
185
1.22
0.51
1.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
29
220
0.80
0.51
1.2
1.7
g/l
12.7
13.2
0.10
22
163
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
7
27
1.58
0.50
1.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
27
1.58
0.50
1.0
1.0
nmol/l
242.3
233.8
—
7
27
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
67
355
1.15
0.50
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
576
3677
0.95
0.50
1.2
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4032
24258
1.02
0.49
2.2
2.3
u/l
240.3
272.8
1.30
3779
22785
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
284
1625
1.07
0.49
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
172
965
1.09
0.49
1.1
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
13
56
1.42
0.48
1.1
1.3
%
1.3
1.3
0.16
13
56
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
40
291
0.84
0.47
3.5
5.8
%
72.3
71.5
0.06
33
250
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
44
226
1.19
0.47
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
123
681
1.10
0.47
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
99
1.30
0.46
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
60
421
0.87
0.46
1.7
1.3
u/l
8.3
6.0
0.41
52
364
(3044927) Protein electrophoresis panel - Urine
157
880
1.09
0.46
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
46
1.46
0.46
1.1
1.1
umol/24h
1.8
2.2
0.61
11
46
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
18
143
0.77
0.46
1.2
1.8
mmol/l
1.2
1.2
0.66
18
138
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
28
138
1.24
0.45
1.3
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
265
1722
0.94
0.45
1.2
1.3
mg/l
609.2
580.4
0.32
249
1638
(3011985) Renin [Units/volume] in Plasma
160
900
1.09
0.44
1.8
1.3
mu/l
80.3
73.1
0.13
140
792
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
33
1.48
0.44
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
101
556
1.11
0.44
1.3
2.0
mmol/l
7.3
7.2
0.05
71
380
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
231
1506
0.94
0.44
1.2
1.2
mmol/l
3.8
4.0
1.99
215
1418
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
274
1.16
0.43
1.5
1.4
nmol/l
0.1
0.1
0.05
41
223
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
84
1.31
0.43
1.6
1.6
umol/l
37.9
44.1
0.54
18
84
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
129
860
0.91
0.43
1.1
1.2
%
112.6
109.6
0.48
112
776
(1761868) Lipid panel - Serum or Plasma
3902
24140
0.98
0.43
3.2
3.2
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
10
0.00
0.43
0.0
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
10
0.00
0.43
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
80
436
1.12
0.42
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1590
9928
0.98
0.41
7.8
7.4
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
5
20
1.53
0.41
1.4
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
43
224
1.17
0.41
1.1
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
25
187
0.82
0.41
1.2
1.3
g/l
0.3
0.3
0.60
17
151
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
137
908
0.92
0.41
1.1
1.2
u/ml
36.6
41.8
—
5
81
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
12
0.00
0.40
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
27
200
0.82
0.40
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
213
0.83
0.40
1.1
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
31
226
0.84
0.40
1.6
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
97
652
0.91
0.39
1.1
1.1
au/ml
72.9
25.7
—
5
12
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
182
1036
1.07
0.39
1.2
1.3
u/ml
278.3
286.2
0.14
114
684
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
100
671
0.91
0.39
1.1
1.2
%
92.3
97.1
0.97
88
626
(3003327) Ova and parasites identified in Stool by Light microscopy
258
1668
0.94
0.39
1.6
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
41
214
1.17
0.39
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
78
530
0.90
0.39
2.5
3.3
%
13.1
13.2
0.58
78
522
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
41
1.34
0.38
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
70
0.70
0.38
1.0
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
22
108
1.24
0.38
1.4
1.3
mmol/l
1.0
0.9
0.01
16
66
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
67
365
1.12
0.37
2.3
2.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
81
1.28
0.36
1.1
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
49
0.62
0.36
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
25
184
0.83
0.36
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
32
230
0.85
0.36
1.2
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
11
49
1.37
0.35
4.2
3.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
13
60
1.32
0.34
1.1
1.1
u/l
14.9
8.4
0.58
13
60
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
27
1.36
0.34
1.0
1.1
%
20.1
22.1
—
6
22
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
27
1.36
0.34
1.0
1.1
%
36.9
36.4
—
6
22
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
27
1.36
0.34
1.0
1.1
%
7.9
8.9
—
6
22
(3013293) Extractable nuclear Ab [Presence] in Serum
6
53
0.69
0.34
1.0
1.7
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
22
110
1.22
0.33
4.2
4.9
ug/min
45.1
48.4
0.09
17
94
(3024263) Appearance of Synovial fluid
75
504
0.91
0.33
1.7
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
145
947
0.93
0.32
1.1
1.1
g/l
1.5
1.6
0.18
131
852
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
31
1.38
0.32
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
115
0.80
0.32
1.2
1.2
%
47.5
51.2
—
6
40
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
7
60
0.71
0.32
1.0
1.2
nmol/l
0.1
0.1
—
7
44
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
83
463
1.09
0.31
1.3
1.3
titre
101.7
93.2
—
6
41
(4027681)
42
291
0.88
0.31
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
62
419
0.90
0.31
1.1
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
7
33
1.30
0.30
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
212
0.86
0.29
1.1
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
25
129
1.18
0.29
1.2
1.2
ng/l
4240.6
135.8
0.52
14
91
(3036670) Protein [Mass/volume] in Synovial fluid
54
296
1.11
0.29
1.1
1.3
g/l
41.5
41.3
0.04
28
163
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
88
582
0.92
0.29
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
73
0.75
0.28
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
56
378
0.90
0.28
1.5
1.3
u/ml
3.2
1.4
0.50
31
221
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
37
256
0.88
0.28
1.1
1.0
iu/ml
30.4
9.8
—
5
63
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
79
1.24
0.28
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
59
396
0.91
0.27
2.0
2.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
103
586
1.07
0.26
1.5
1.7
umol/l
77.1
75.5
—
7
35
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
46
0.66
0.26
1.4
1.4
—
—
—
0
0
(4133840)
35
242
0.88
0.26
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
125
0.83
0.26
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
310
1966
0.96
0.26
1.7
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
192
1231
0.95
0.26
1.7
1.8
mu/l
253.2
256.7
0.09
185
1153
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
65
363
1.09
0.26
1.1
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
80
1.22
0.25
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
51
282
1.10
0.25
1.1
1.1
ng/l
504.5
696.5
0.19
16
72
(3000285) Sodium [Moles/volume] in Blood
15
111
0.82
0.25
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
138
797
1.06
0.24
3.3
3.0
mg/l
38.0
53.1
0.53
106
604
(3022689) Creatine [Moles/volume] in Urine
44
242
1.11
0.24
1.6
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
84
0.80
0.24
1.2
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
23
1.33
0.23
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
149
864
1.05
0.23
1.4
1.6
iu/l
4.7
15.5
0.46
36
274
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
33
179
1.13
0.22
1.1
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
7
0.00
0.22
0.0
3.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
101
655
0.94
0.22
1.4
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.21
0.0
2.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
44
295
0.91
0.21
1.0
1.1
u/l
1.1
1.0
0.36
21
140
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
206
1309
0.96
0.21
1.1
1.2
u/ml
3.3
7.8
—
10
133
(3036180) Methadone [Presence] in Urine
0
9
0.00
0.21
0.0
2.8
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
9
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
92
528
1.06
0.20
2.4
2.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
71
0.77
0.20
1.1
1.1
—
—
—
0
0
(44806420)
42
281
0.91
0.20
2.5
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
109
702
0.95
0.20
1.2
1.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
17
121
0.86
0.20
1.2
1.4
%
75.2
72.2
0.70
17
114
(3001729) Color of Synovial fluid
15
77
1.19
0.19
1.2
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
19
100
1.16
0.19
1.2
1.1
umol/24h
0.8
0.7
0.07
11
46
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
25
172
0.89
0.19
1.2
1.2
%
125.4
110.2
1.44
19
155
(3025315) Body weight
16
83
1.18
0.19
4.5
4.8
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
17
120
0.86
0.18
1.2
1.4
mu/l
330.0
834.5
0.87
17
113
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
81
0.83
0.18
7.2
10.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
11
55
1.22
0.18
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
58
379
0.93
0.17
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
58
379
0.93
0.17
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
338
2117
0.97
0.17
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
210
1325
0.97
0.17
1.1
1.2
u/ml
3.7
7.9
1.51
16
196
(3044009) aPTT.lupus sensitive (LA screen)
8
42
1.16
0.17
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
161
946
1.04
0.17
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
93
0.85
0.16
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
58
378
0.94
0.16
1.2
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
26
176
0.90
0.16
1.3
1.5
ug/l
11.5
9.7
0.74
26
176
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
47
1.17
0.16
2.2
2.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
19
102
1.14
0.15
1.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
53
346
0.93
0.15
31.1
35.9
ug/l
7.2
7.4
0.44
44
316
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
348
2175
0.98
0.15
1.1
1.1
iu/ml
115.8
106.2
0.19
105
758
(3023410) Appearance of Cerebral spinal fluid
97
620
0.95
0.15
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
248
1473
1.03
0.15
1.2
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
35
232
0.92
0.15
1.5
1.3
%
38.2
35.9
0.12
28
150
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
124
0.89
0.14
5.7
4.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
59
382
0.94
0.14
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
59
382
0.94
0.14
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
63
407
0.94
0.14
1.1
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
111
0.88
0.14
1.4
1.4
%
83.0
84.7
—
7
53
(3041918) Cholesterol [Moles/volume] in Pleural fluid
27
150
1.10
0.14
1.3
1.2
mmol/l
1.7
1.3
1.35
20
83
(4268621)
92
587
0.96
0.13
2.3
2.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
59
381
0.95
0.13
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
312
1947
0.98
0.13
2.1
2.9
umol/l
30.7
34.0
1.89
252
1663
(3028717) Thiamine [Mass/volume] in Blood
9
65
0.85
0.13
1.4
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
249
1558
0.98
0.13
1.5
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
123
0.89
0.13
1.9
1.1
%
66.3
80.8
—
8
74
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
78
499
0.95
0.13
2.2
2.2
ug/min
62.1
172.1
1.47
24
135
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
89
567
0.96
0.13
1.0
1.1
u/ml
3.1
3.7
0.18
31
234
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
140
883
0.97
0.12
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
275
1643
1.02
0.12
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
34
223
0.93
0.12
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
31
204
0.93
0.12
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
31
204
0.93
0.12
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
31
204
0.93
0.12
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
31
204
0.93
0.12
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
89
522
1.04
0.11
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
142
841
1.03
0.11
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
146
918
0.97
0.11
1.3
1.3
u/ml
4.7
4.5
0.04
56
335
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
141
887
0.97
0.11
1.3
1.3
u/ml
3.8
4.1
0.12
64
433
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
48
310
0.95
0.11
1.2
1.2
%
81.5
51.0
—
6
23
(3033799) Differential panel - Peritoneal fluid
41
235
1.07
0.11
1.3
2.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
52
1.17
0.11
1.1
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
30
170
1.08
0.11
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
55
320
1.05
0.10
1.1
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
74
434
1.04
0.10
1.1
1.2
mmol/l
36.9
34.3
0.52
58
372
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
28
1.09
0.10
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
108
0.90
0.09
1.1
1.3
%
77.1
74.9
—
7
49
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
29
1.05
0.09
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
32
183
1.07
0.09
1.0
1.3
umol/l
10.8
12.4
0.16
25
130
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
24
158
0.93
0.09
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
37
239
0.94
0.09
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
106
1.09
0.09
1.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
53
1.15
0.09
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
273
1695
0.98
0.09
1.2
1.2
titre
88.0
159.5
—
5
37
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
34
1.08
0.09
1.3
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
53
338
0.96
0.08
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
59
1.14
0.08
1.0
1.1
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
35
1.05
0.08
1.0
1.2
u/l
200.5
271.3
—
6
28
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
38
0.80
0.08
1.2
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
31
178
1.06
0.08
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
31
178
1.06
0.08
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
681
4196
0.99
0.08
2.4
2.4
au/ml
41.4
25.0
0.82
23
158
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
41
1.04
0.08
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
273
1641
1.02
0.08
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
271
1629
1.02
0.08
1.2
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
74
467
0.97
0.08
1.4
1.5
umol/l
14.9
14.9
0.01
67
433
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
80
504
0.97
0.08
1.0
1.1
mg/l
278.3
272.9
0.31
73
460
(3039443) Prostate specific Ag panel - Serum or Plasma
504
3044
1.01
0.08
2.1
1.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
46
0.80
0.08
1.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
18
101
1.09
0.07
1.6
2.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
20
113
1.08
0.07
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
59
347
1.04
0.07
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
625
3781
1.01
0.07
1.3
1.3
au/ml
65.7
50.8
0.71
35
173
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
7
49
0.87
0.07
1.1
1.2
u/l
6100.0
268.2
—
7
42
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
52
1.06
0.07
2.1
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
366
2260
0.99
0.07
1.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
162
0.94
0.06
1.6
1.8
ng/l
116.6
152.1
0.76
25
162
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
9
63
0.87
0.06
1.6
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
41
261
0.96
0.06
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
93
0.92
0.06
1.1
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
19
124
0.94
0.06
1.3
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
65
408
0.97
0.05
1.4
1.3
g/l
1.3
1.5
—
5
30
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
80
0.92
0.05
1.2
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
80
0.92
0.05
1.8
1.4
ml/s/173m2
0.8
1.0
—
7
56
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
80
0.92
0.05
3.1
2.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
17
111
0.93
0.05
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
30
175
1.05
0.05
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
91
1.07
0.04
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
42
248
1.03
0.04
1.5
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
263
1594
1.01
0.03
2.9
2.8
nmol/l
0.8
0.8
0.02
190
1212
(3004616) Nuclear Ab [Presence] in Serum
122
736
1.01
0.03
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
69
414
1.02
0.02
1.1
1.1
mg/l
55.2
46.2
0.74
58
355
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
17
109
0.95
0.02
1.2
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
336
0.98
0.02
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
49
293
1.02
0.02
1.4
1.6
umol/l
67.4
91.1
0.61
22
137
(4015189)
40
250
0.98
0.02
2.5
2.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
179
1085
1.01
0.02
1.5
1.6
u/ml
108.3
114.6
0.37
38
238
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
184
1131
0.99
0.02
1.1
1.2
u/ml
1.3
6.9
—
8
92
(3050794) Legionella sp Ab [Presence] in Serum
13
84
0.94
0.02
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
535
3256
1.00
0.02
2.3
2.5
ug/l
565.1
611.9
0.14
518
3098
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
65
391
1.01
0.02
1.0
1.1
mg/l
355.0
331.3
0.30
54
349
(3023487) Leukocytes [#/volume] in Peritoneal fluid
44
274
0.98
0.01
1.4
2.4
e6/l
1048.4
2494.9
0.40
35
198
(40757373) Influenza virus identified in Isolate
28
166
1.03
0.01
1.5
1.9
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
14
81
1.06
0.01
1.1
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
38
237
0.98
0.01
1.4
2.3
e6/l
28787.2
5840.1
0.61
25
130
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
23
136
1.03
0.01
1.3
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
97
587
1.01
0.01
1.7
1.6
u/ml
36.9
28.2
0.59
18
131
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
57
1.07
0.01
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
105
646
0.99
0.01
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
20
126
0.97
0.00
1.2
1.1
%
81.7
81.0
—
10
76
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
29
181
0.98
0.00
2.9
2.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
67
1.00
0.00
1.2
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
63
0.97
0.00
1.1
1.0
—
—
—
0
0
(44806071)
13
80
0.99
0.00
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
27
162
1.02
0.00
1.5
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
21
129
0.99
0.00
1.5
1.2
titre
269.2
178.0
—
5
11
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
47
284
1.01
0.00
1.6
1.4
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
25
152
1.00
0.00
1.1
1.2
mg/l
206.2
14.1
0.44
19
113
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
169
1030
1.00
0.00
1.5
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
108
662
1.00
0.00
1.9
2.0
ug/l
4.2
3.5
0.30
89
585
(3002523) Influenza virus A Ag [Presence] in Specimen
106
646
1.00
0.00
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
30
181
1.01
0.00
1.2
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
202
1233
1.00
0.00
1.1
1.2
—
13.8
—
0
15
(3044290) Cell count panel - Cerebral spinal fluid
220
1343
1.00
0.00
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
60
369
0.99
0.00
1.1
1.1
—
—
—
0
0
(4146454)
178
1090
1.00
0.00
2.5
2.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
40
247
0.99
0.00
1.1
1.1
miu/ml
1448.9
1609.7
0.35
40
247
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
121
1.01
0.00
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
60
368
1.00
0.00
1.5
1.5
—
—
—
0
0
(4281824)
32
195
1.00
0.00
1.1
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
69
0.97
0.00
3.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
34
209
0.99
0.00
1.3
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
62
0.98
0.00
1.1
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
106
645
1.00
0.00
2.0
2.0
ug/l
2.4
1.9
0.44
86
538
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
8
52
0.94
0.00
1.1
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
58
0.95
0.00
1.1
1.3
umol/24h
383.1
345.8
—
9
58
(3013336) Amino acids [Identifier] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
41
0.89
0.00
7.5
9.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
40
0.92
0.00
1.3
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
30
1.02
0.00
1.4
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
48
0.89
0.00
1.0
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
31
0.98
0.00
1.4
1.5
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
134.1
—
0
6
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
36
0.85
0.00
11.0
7.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
31
0.98
0.00
1.0
1.0
—
—
—
0
0
(3001488) Cow milk IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
2.3
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MALE_GENITAL_EXALLC – malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).